| Financial Year |
March 31 2023 |
| Monetary Funds |
190,825,335.82 |
| Held-for-trading Financial Assets |
320,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
26,199,892.56 |
| Advances to Suppliers |
123,499.68 |
| Other Receivables |
7,786,409.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,658,844,762.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
167,539,522.05 |
| Total Current Assets |
2,372,921,904.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,883,911.86 |
| Investment Properties |
81,896,593.52 |
| Fixed Assetes |
5,496,735.54 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
338,272.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
30,879,429.92 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
141,641,165.27 |
| Total Assets |
2,514,563,070.05 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
62,816,573.89 |
| Accounts Received In Advance |
9,477,738.55 |
| Employee Compensation Payable |
3,493,823.55 |
| Taxes Payable |
115,963,278.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
148,346,340.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
77,919,061.14 |
| Other Current Liabilities |
78,141,319.64 |
| Sub-Total of Current Liabilities |
1,366,210,564.66 |
| Long-term Loans |
10,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
396,701.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,396,701.62 |
| Total Liabilities |
1,376,607,266.28 |
| Paid-In Capital(Or Share Stock) |
206,282,429.00 |
| Capital Surplus |
543,070,669.40 |
| Surplus Reserve |
99,253,481.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
283,376,535.22 |
| Minority Stockholder's Interest |
5,504,240.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,132,451,563.01 |
| Owner's Equity（Stockholder's Equity） |
1,137,955,803.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,514,563,070.05 |
